PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
24.79
Positive P/E while Healthcare median is negative at -1.87. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
2.44
P/S less than half the Healthcare median of 8.92. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
2.43
P/B 1.1-1.25x Healthcare median of 2.06. John Neff would demand superior ROE to justify premium.
55.82
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash flow generation advantage.
55.82
Positive operating cash flow while Healthcare median is negative. Peter Lynch would examine operational advantage.
2.43
Fair value ratio 1.1-1.25x Healthcare median of 2.06. John Neff would demand superior metrics to justify premium.
1.01%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
1.79%
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash generation advantage.